TRACON Pharmaceuticals Investor Relations Material

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. The company is engaged in developing novel oral small molecule drugs that target specific intracellular signaling molecules involved in cancer cell growth and survival. The Company's portfolio of cancer therapeutics includes TRACON-1, a next-generation monoclonal antibody product candidate targeting the tumor microenvironment.